CJC-1295 + Ipamorelin (No DAC) Research Blend

CJC-1295 + Ipamorelin (No DAC) is a laboratory research peptide blend containing two peptides in a single vial. Each vial contains 5 mg of CJC-1295 without DAC (drug affinity complex), also referred to as Modified GRF (1-29), and 5 mg of Ipamorelin, for a total peptide content of 10 mg. The product is supplied in lyophilized, or freeze-dried, powder form.
CJC-1295 without DAC is a synthetic analogue of growth hormone–releasing hormone (GHRH) studied in research involving GHRH receptor signaling. Ipamorelin is a synthetic pentapeptide studied as a selective ghrelin receptor (GHSR-1a) agonist. Because the two compounds act on distinct receptors, published research has examined them together when studying growth hormone secretagogue pathways.
Intended for qualified researchers and institutions conducting laboratory work. Researchers should assess whether the formulation and available supporting documentation meet the requirements of their particular experimental methods before purchasing.
Laboratory personnel should follow their institution’s established procedures for receiving, labeling, storing, and handling research materials. Any preparation or reconstitution should be performed by appropriately trained personnel using methods and materials suitable for the intended laboratory application.
CJC-1295 + Ipamorelin (No DAC) is supplied for laboratory research use only. It is not intended for human or animal consumption, clinical administration, or use in diagnosing, treating, curing, or preventing disease. Purchase and use are limited to legitimate laboratory research purposes.